HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A V Krylatov Selected Research

methanandamide

1/2007[Significance of cardiac cannabinoid receptors in regulation of cardiac rhythm, myocardial contractility, and electrophysiologic processes in heart].
5/2002[Anandamide and R-(+)-methanandamide prevent development of ischemic and reperfusion arrhythmia in rats by stimulation of CB2-receptors].
2/2002Endogenous cannabinoids improve myocardial resistance to arrhythmogenic effects of coronary occlusion and reperfusion: a possible mechanism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A V Krylatov Research Topics

Disease

21Ischemia
03/2021 - 11/2000
9Infarction (Infarctions)
03/2021 - 01/2001
8Coronary Occlusion
10/2010 - 06/2001
4Reperfusion Injury
01/2014 - 05/2002
4Cardiac Arrhythmias (Arrythmia)
11/2004 - 03/2000
3Ventricular Fibrillation
04/2003 - 01/2001
2Bradycardia
01/2007 - 10/2006
2Fibrosis (Cirrhosis)
04/2003 - 07/2002
2Necrosis
05/2002 - 02/2002
1Heart Injuries
01/2014
1No-Reflow Phenomenon
01/2014
1Atrial Remodeling
01/2008
1Hypoxia (Hypoxemia)
08/2006
1Ganglion Cysts (Ganglion)
04/2006
1Sclerosis
04/2003
1Myocardial Infarction
02/2002

Drug/Important Bio-Agent (IBA)

10HU 211 (HU 210)IBA
09/2014 - 06/2001
8Opioid Receptors (Opioid Receptor)IBA
03/2021 - 11/2003
7Cannabinoid Receptors (Cannabinoid Receptor)IBA
07/2008 - 06/2001
6ChloraloseIBA
03/2021 - 06/2001
6Opioid Analgesics (Opioids)IBA
03/2017 - 01/2001
6CannabinoidsIBA
09/2014 - 02/2002
5SolutionsIBA
01/2012 - 11/2000
5LigandsIBA
10/2010 - 03/2000
4D-Penicillamine (2,5)- EnkephalinIBA
03/2021 - 11/2003
4Adenosine Triphosphate (ATP)IBA
10/2010 - 11/2001
4KATP ChannelsIBA
06/2009 - 07/2002
3Ala(2)- deltorphin IIIBA
03/2021 - 06/2009
3methanandamideIBA
01/2007 - 02/2002
3anandamide (arachidonylethanolamide)IBA
01/2007 - 02/2002
3CB2 Cannabinoid ReceptorIBA
10/2006 - 05/2002
3sigma Receptors (sigma Receptor)IBA
01/2001 - 03/2000
2Naltrexone (ReVia)FDA LinkGeneric
03/2021 - 06/2008
2Adenosine (Adenocard)FDA LinkGeneric
01/2014 - 03/2012
2Creatine Kinase (Creatine Phosphokinase)IBA
01/2012 - 07/2008
2Protein Kinase CIBA
10/2010 - 06/2009
2Nociceptin ReceptorIBA
06/2009 - 11/2004
2SR 144528IBA
07/2008 - 10/2006
2kappa Opioid Receptors (kappa Opioid Receptor)IBA
06/2008 - 01/2001
2Hexamethonium (Hexamethonium Bromide)IBA
04/2006 - 11/2004
2tyrosyl-arginyl-phenylalanyl-lysinamide (DALDA)IBA
11/2003 - 07/2002
2Cannabinoid Receptor AgonistsIBA
02/2002 - 06/2001
1naltrindole benzofuranIBA
03/2021
1N-methylnaloxoneIBA
03/2021
1BW 373U86IBA
03/2021
1Toxic ActionsIBA
03/2021
1ICI 199441IBA
10/2015
1Purinergic P1 Receptor AgonistsIBA
01/2014
1Morphine (MS Contin)FDA LinkGeneric
01/2014
1ElementsIBA
01/2013
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
01/2013
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2013
1BradykininIBA
03/2012
1Glyburide (Glibenclamide)FDA LinkGeneric
10/2010
1chelerythrineIBA
10/2010
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
07/2008
1RimonabantIBA
07/2008
1Opioid Peptides (Opioid Peptide)IBA
06/2008
1quadazocineIBA
06/2008
1Ala(2)-Arg(6)- enkephalin-LeuIBA
06/2008
1GR 89696IBA
06/2008
1Pharmaceutical PreparationsIBA
05/2008
1Plant Preparations (Preparation, Plant)IBA
08/2006
1Ether (Diethyl Ether)IBA
11/2004
1AconitineIBA
11/2004
1NociceptinIBA
11/2004
1ORALIT (ORS)IBA
11/2003
1Potassium Channels (Potassium Channel)IBA
11/2003
1BMS 180448IBA
04/2003
1HMR 1098IBA
04/2003
1Diazoxide (Hyperstat)FDA Link
04/2003
1CatecholaminesIBA
04/2003
1Thr(6)- Leu(5) Ser(2) enkephalinIBA
10/2002
1mu Opioid Receptors (mu Opioid Receptor)IBA
07/2002
1Nitric Oxide Synthase (NO Synthase)IBA
02/2002
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
02/2002
1EnzymesIBA
02/2002
1Anti-Arrhythmia AgentsIBA
11/2000
1DuP 734IBA
11/2000

Therapy/Procedure

4Intravenous Administration
01/2007 - 07/2002
1Percutaneous Coronary Intervention
01/2014
1Intravenous Infusions
01/2014
1Ischemic Postconditioning
03/2012
1Transplantation
01/2008
1Injections
11/2004
1Intravenous Injections
06/2001